Literature DB >> 19741567

Selective serotonin reuptake inhibitors pathway.

Katrin Sangkuhl1, Teri E Klein, Russ B Altman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19741567      PMCID： PMC2896866          DOI： 10.1097/FPC.0b013e32833132cb

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN： 1744-6872            Impact factor:   2.089


× No keyword cloud information.
  22 in total

Review 1.  Emerging role of glutamate in the pathophysiology of major depressive disorder.

Authors:  Kenji Hashimoto
Journal:  Brain Res Rev       Date:  2009-05-28

Review 2.  Physiology and pathophysiology of the serotonergic system and its implications on mental and physical performance. Part I.

Authors:  H K Strüder; H Weicker
Journal:  Int J Sports Med       Date:  2001-10       Impact factor: 3.118

Review 3.  Pharmacokinetics of selective serotonin reuptake inhibitors.

Authors:  C Hiemke; S Härtter
Journal:  Pharmacol Ther       Date:  2000-01       Impact factor: 12.310

Review 4.  Molecular biology of 5-HT receptors.

Authors:  Jason Hannon; Daniel Hoyer
Journal:  Behav Brain Res       Date:  2008-03-25       Impact factor: 3.332

Review 5.  Sertraline versus other antidepressive agents for depression.

Authors:  Andrea Cipriani; Teresa La Ferla; Toshi A Furukawa; Alessandra Signoretti; Atsuo Nakagawa; Rachel Churchill; Hugh McGuire; Corrado Barbui
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15

6.  Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments.

Authors:  Darrick T Balu; Brian A Hoshaw; Jessica E Malberg; Sharon Rosenzweig-Lipson; Lee E Schechter; Irwin Lucki
Journal:  Brain Res       Date:  2008-03-21       Impact factor: 3.252

Review 7.  Serotonin type 3 receptor genes: HTR3A, B, C, D, E.

Authors:  Beate Niesler; Johannes Kapeller; Christian Hammer; Gudrun Rappold
Journal:  Pharmacogenomics       Date:  2008-05       Impact factor: 2.533

Review 8.  Review: Bupropion and SSRI-induced side effects.

Authors:  K Demyttenaere; L Jaspers
Journal:  J Psychopharmacol       Date:  2008-02-28       Impact factor: 4.153

9.  Long-term treatment with fluoxetine induces desensitization of 5-HT4 receptor-dependent signalling and functionality in rat brain.

Authors:  Rebeca Vidal; Elsa M Valdizán; Ricardo Mostany; Angel Pazos; Elena Castro
Journal:  J Neurochem       Date:  2009-06-09       Impact factor: 5.372

Review 10.  Pharmacogenetics of antidepressant response: an update.

Authors:  Antonio Drago; Diana De Ronchi; Alessandro Serretti
Journal:  Hum Genomics       Date:  2009-04       Impact factor: 4.639
View more
  20 in total

Review 1.  Identifying genetic loci affecting antidepressant drug response in depression using drug-gene interaction models.

Authors:  Raymond Noordam; Christy L Avery; Loes E Visser; Bruno H Stricker
Journal:  Pharmacogenomics       Date:  2016-06-01       Impact factor: 2.533

2.  Effect of the 5-HTTLPR polymorphism on posttraumatic stress disorder, depression, anxiety, and quality of life among Iraq and Afghanistan veterans.

Authors:  Nathan A Kimbrel; Sandra B Morissette; Eric C Meyer; Roberta Chrestman; Robert Jamroz; Paul J Silvia; Jean C Beckham; Keith A Young
Journal:  Anxiety Stress Coping       Date:  2014-11-14

Review 3.  Novel aspects of enteric serotonergic signaling in health and brain-gut disease.

Authors:  Andrew Del Colle; Narek Israelyan; Kara Gross Margolis
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-11-04       Impact factor: 4.052

4.  PharmGKB: the Pharmacogenomics Knowledge Base.

Authors:  Caroline F Thorn; Teri E Klein; Russ B Altman
Journal:  Methods Mol Biol       Date:  2013

Review 5.  PharmGKB summary: citalopram pharmacokinetics pathway.

Authors:  Katrin Sangkuhl; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2011-11       Impact factor: 2.089

Review 6.  The effect of ketamine on anhedonia: improvements in dimensions of anticipatory, consummatory, and motivation-related reward deficits.

Authors:  Danica Nogo; Ashitija K Jasrai; Haeun Kim; Flora Nasri; Felicia Ceban; Leanna M W Lui; Joshua D Rosenblat; Maj Vinberg; Roger Ho; Roger S McIntyre
Journal:  Psychopharmacology (Berl)       Date:  2022-03-15       Impact factor: 4.530

Review 7.  The Prostaglandin Transporter: Eicosanoid Reuptake, Control of Signaling, and Development of High-Affinity Inhibitors as Drug Candidates.

Authors:  Victor L Schuster; Yuling Chi; Run Lu
Journal:  Trans Am Clin Climatol Assoc       Date:  2015

Review 8.  Extreme enhancement or depletion of serotonin transporter function and serotonin availability in autism spectrum disorder.

Authors:  Valentina R Garbarino; T Lee Gilman; Lynette C Daws; Georgianna G Gould
Journal:  Pharmacol Res       Date:  2018-07-24       Impact factor: 7.658

9.  PharmGKB summary: sertraline pathway, pharmacokinetics.

Authors:  Rachel Huddart; J Kevin Hicks; Laura B Ramsey; Jeffrey R Strawn; D Max Smith; Margarita Bobonis Babilonia; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2020-02       Impact factor: 2.000

10.  Whole-genome association analysis of treatment response in obsessive-compulsive disorder.

Authors:  H Qin; J F Samuels; Y Wang; Y Zhu; M A Grados; M A Riddle; B D Greenberg; J A Knowles; A J Fyer; J T McCracken; D L Murphy; S A Rasmussen; B A Cullen; J Piacentini; D Geller; S E Stewart; D Pauls; O J Bienvenu; F S Goes; B Maher; A E Pulver; D Valle; C Lange; M Mattheisen; N C McLaughlin; K-Y Liang; E L Nurmi; K D Askland; G Nestadt; Y Y Shugart
Journal:  Mol Psychiatry       Date:  2015-03-31       Impact factor: 15.992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.